Standard BioTools Inc.

LAB | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.74

-$0.03 (-3.87%)

At close: Sep 21, 2026, 4:00 PM ET

$0.73

-$0.01 (-1.35%)

Pre-market: Sep 22, 2026, 4:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-74.9M	-138.89M	-74.66M	-190.1M	-59.24M	-53.02M
Depreciation & Amortization	1.72M	16.86M	15.18M	15.03M	16.2M	15.92M
Stock-Based Compensation	29.61M	31.73M	13.12M	14.88M	16.1M	14.45M
Other Working Capital	-34.53M	-11.17M	8.07M	-4.95M	-19.95M	15.32M
Other Non-Cash Items	14.2M	-41.08M	1.28M	83.17M	886K	4.6M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	212K
Change in Working Capital	-44.98M	-12.08M	1.79M	-12.35M	-18.01M	2.41M
Operating Cash Flow	-74.35M	-143.45M	-43.29M	-89.37M	-44.06M	-15.42M
Capital Expenditures	-8.3M	-8.36M	-2.83M	-3.83M	-13.26M	-12.72M
Cash Acquisitions	n/a	278.65M	n/a	n/a	n/a	-5.15M
Purchase of Investments	-140.93M	n/a	-94.9M	n/a	n/a	n/a
Sales Maturities Of Investments	179M	n/a	117.96M	n/a	n/a	36.81M
Other Investing Acitivies	-5M	92.88M	n/a	-84.3M	1.32M	21.04M
Investing Cash Flow	24.77M	363.17M	20.24M	-88.13M	-11.95M	39.98M
Debt Repayment	n/a	-63.19M	-2.08M	18.16M	9.5M	n/a
Common Stock Repurchased	n/a	-40.95M	-5.41M	-774K	-1.79M	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-484K	1.53M	827K	213.37M	8.25M	631K
Financial Cash Flow	570K	-102.62M	-6.81M	230.76M	15.96M	20.86M
Net Cash Flow	-48.17M	116.32M	-29.83M	52.86M	-40.07M	45.8M
Free Cash Flow	-82.65M	-151.81M	-46.12M	-93.2M	-57.33M	-28.13M
Adj. Free Cash Flow	-112.27M	-183.54M	-59.24M	-108.08M	-73.43M	-42.59M
Maintenance CapEx	-8.3M	n/a	-24.88K	-3.83M	-13.26M	-9.21M
Growth CapEx	n/a	-8.36M	-2.81M	n/a	n/a	-3.51M
Owner Earnings	-82.65M	-143.45M	-43.31M	-93.2M	-57.33M	-24.62M